---
title: Publications
view: 4

header:
  caption: ""
  image: ""
---


## <span style="color:green"> *Preprints* </span>
**Zhao, S**\*\# Crouse, W\*,Qian, S, Luo, K, Stephens, M\#, He, X\#.  [Adjusting for genetic confounders in transcriptome-wide association studies improves discovery of risk genes of complex traits.](https://www.nature.com/articles/s41588-023-01648-9) *Nat. Genet.* **56**, 336–347 (2024).  
 \# co-corresponding author \* co-first author

## <span style="color:green"> *2021* </span>

Choi, J. et al. [Integrated mutational landscape analysis of uterine leiomyosarcomas](https://www.pnas.org/doi/abs/10.1073/pnas.2025182118). Proc. Natl. Acad. Sci. U. S. A. 118, (2021)

## <span style="color:green"> *2020* </span>

Zhang S\*, Zhang H\*, Zhou Y\*, Qiao M\*, **Zhao S**\* *et al*. [Allele-specific open chromatin in human iPSC neurons elucidates functional disease variants.](https://science.sciencemag.org/content/369/6503/561.abstract) *Science* 2020; 369: 561–565.  
\* co-first author

## <span style="color:green"> *2019* </span>

**Zhao S**, Liu J, Nanga P *et al*. [Detailed modeling of positive selection improves detection of cancer driver genes.](https://www.nature.com/articles/s41467-019-11284-9) *Nature communications* 2019; 10: 1–13.13 

Zammataro L, Lopez S, Bellone S *et al*. [Whole-exome sequencing of cervical carcinomas identifies activating erbb2 and pik3ca mutations as targets for combination therapy.](https://www.pnas.org/content/116/45/22730.short) *Proceedings of the National Academy of Sciences* 2019; 116: 22730–22736.
14 

## <span style="color:green"> *2018* </span>

Ward MC, **Zhao S**, Luo K *et al*. [Silencing of transposable elements may not be a major driver of regulatory evolution in primate iPSCs.](https://elifesciences.org/articles/33084) *Elife* 2018; 7: e33084.

Liu Y, Liang Y, Cicek AE *et al*. [A statistical framework for mapping risk genes from de novo mutations in whole-genome-sequencing studies.](https://www.sciencedirect.com/science/article/pii/S0002929718301125) *The American Journal of Human Genetics* 2018; 102: 1031–1047.

## <span style="color:green"> *2016* </span>

**Zhao S**, Bellone S, Lopez S *et al*. [Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial–mesenchymal transition.](https://www.pnas.org/content/113/43/12238.short) *Proceedings of the National Academy of Sciences* 2016; 113: 12238–12243.

Bi M, **Zhao S**, Said JW *et al*. [Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma.](https://www.pnas.org/content/113/8/2170.short) *Proceedings of the National Academy of Sciences* 2016; 113: 2170–2175.

Cocco E, Lopez S, Black J *et al*. [Dual ccne1/pik3ca targeting is synergistic in ccne1-amplified/pik3ca-mutated uterine serous carcinomas in vitro and in vivo.](https://www.nature.com/articles/bjc2016198) *British journal of cancer* 2016; 115: 303–311.

## <span style="color:green"> *2014* </span>

**Zhao S**, Choi M, Heuck C *et al*. [Serial exome analysis of disease progression in premalignant gammopathies.](https://www.nature.com/articles/leu201459) *Leukemia* 2014; 28: 1548–1552

## <span style="color:green"> *2013* </span>

**Zhao S**, Choi M, Overton JD *et al*. [Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma.](https://www.pnas.org/content/110/8/2916.short) *Proceedings of the National Academy of Sciences* 2013; 110: 2916–2921.
